Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Kaiser Permanente study presented at international conference suggests moving once a year or more makes it harder for people with type 2 diabetes to adhere to their medications.
Kaiser Permanente study is the first to compare early telehealth approach to early in-person follow-up to prevent hospital readmissions.
People who recovered from active tuberculosis had a higher long-term risk of death from any cause than similar patients who never had active tuberculosis shows a new Kaiser Permanente study.
Richard Grant, MD, MPH, a research scientist at the Kaiser Permanente Division of Research, has received a $3.2 million, 5-year National Institutes of Health Institute on Aging grant to develop an online education program that uses advance care planning concepts to improve diabetes care for adults age 75 and older.
Listen to our new KP Research Radio episode and learn more about the risks and benefits of the PSA test to screen for prostate cancer.
Teenagers who question their gender identity may not feel comfortable bringing up the issue with their doctors. New research suggests that adding gender identity questions to a pre-visit screening could make those conversations easier.
A Kaiser Permanente analysis of women who did not get flu shots during their pregnancies found the women clustered in geographic “hot spots.” These women tended to have fewer prenatal medical visits and live in low-income neighborhoods.
Clinical psychologist and mental health services researcher Esti Iturralde, PhD, aims to improve the overall health of people with mental illness.
New research from Kaiser Permanente that followed a large number of people living with HIV over 15 years finds reduced risk of certain cancers is among the benefits of early treatment.
The Division of Research has joined a phase 3 clinical trial testing a Pfizer/BioNTech vaccine against the COVID-19 virus. Kaiser Permanente Southern California and Northwest join them in this global effort.